Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1987-7-20
pubmed:abstractText
Cell surface markers have identified considerably more heterogeneity within human T, B, and myeloid neoplasms than was evident by standard morphologic and histochemical techniques. Using markers specific for the lineage and state of differentiation, it is now possible to correlate malignant lymphoid and myeloid cells to their normal cellular counterparts. Considering the complexity of the normal hematopoietic system with regard to ontogeny, differentiation, and function, it is not surprising that these malignancies reflect this diversity. Hopefully, with increasing characterization of the normal function of cell surface molecules, as well as the subpopulations of normal cells to which these malignancies correspond, we will have a better understanding of the biologic and clinical behavior of these malignancies.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0093-7754
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
193-212
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Cell surface markers in hematologic malignancies.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review